IMU 3.77% 5.1¢ imugene limited

can't believe this, page-3

  1. 27 Posts.
    I agree. I guess some are indiscriminantly lumping IMU in with those other 1/4 of biotechs which may face financial difficulty in the coming months. Certainly this is not the case here. IMU is one of few which will run cash flow positive... a very strong position in these turbulent times. IMO DYOR



    Extract from the Quarterly Report

    October – December 2008 - Quarter Highlights:
    -Strategic Alliance signed with Merial Limited – 31 December 2008
    -Initial income totaling US$2 million (AUD$2.9 million) received on 31 December 2008
    -Strategic Alliance income exceeds AUD$30 million to Imugene within next 7 years
    -Additional income from further sub-license fees and milestone payments on individual products and ultimately royalties on sales
    -Imugene translates recent trial successes into a solid income stream
    -Cashflow positive for the half year
    -Strong cash income stream from IP achieved well in advance of product sales
    -Imugene now in a secure financial position moving forward
    -No foreseeable need to raise further capital
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.1¢
Change
-0.002(3.77%)
Mkt cap ! $373.3M
Open High Low Value Volume
5.2¢ 5.2¢ 5.0¢ $669.7K 13.07M

Buyers (Bids)

No. Vol. Price($)
6 1074997 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 1209633 6
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.